Metronidazole resistance in Helicobacter pylori

International Journal of Antimicrobial Agents

Volumn 19, Issue 1, 2002, Pages 1-7

  Jenks, Peter J ^a   Edwards, David I ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

Helicobacter pylori; Metronidazole; Reductase; Resistance; Susceptibility testing

Indexed keywords

FERREDOXIN; METRONIDAZOLE; NITRITE REDUCTASE; OXIDOREDUCTASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL GENE; BACTERIAL INFECTION; BIOPSY; CLINICAL PRACTICE; DNA STRAND BREAKAGE; DRUG EFFICACY; DRUG MECHANISM; ENZYME INACTIVATION; GENE MUTATION; GENETIC CODE; HELICOBACTER PYLORI; NONHUMAN; PRIORITY JOURNAL; REVIEW; VALIDATION PROCESS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; FORECASTING; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MEMBRANE PROTEINS; METRONIDAZOLE; MUTATION;

EID: 0036158830     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00468-X     Document Type: Review

References (67)

1. Helicobacter pylori
2. Helicobacter pylori infection and the risk of gastric carcinoma
3. Helicobacter pylori: Microbiology of a 'slow' bacterial infection
4. Helicobacter pylori infection and gastric lymphoma
5. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
6. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance
7. Antibiotic resistance in Helicobacter pylori: Implications for therapy
8. Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice
9. Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice
10. A systematic review of Helicobacter pylori eradication therapy - The impact of antimicrobial resistance on eradication rates
11. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: A meta-analytical approach
12. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole containing anti-Helicobacter pylori regimens: A meta-analysis
13. Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain
14. Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in The Netherlands
15. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles
16. Generation of free radicals from metronidazole and other nitroimidazoles by Trichomonas foetus
17. Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs
18. The selective toxicity of antimicrobial nitroheterocyclic drugs
19. Nitroimidazole drugs - Action and resistance mechanisms. I. Mechanisms of action
20. The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms
21. Distribution of metronidazole susceptibility factors in obligate anaerobes
22. Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis
23. Nitroimidazole drugs - Action and resistance mechanisms. II. Mechanisms of resistance
24. Characterisation and purification of pyruvate: Ferredoxin oxidoreductase from Giardia duodenalis
25. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase
26. Distinct reduction of nitrofurans and metronidazole to free radical metabolites by Trichomonas foetus hydrogenosomal and cytosolic enzymes
27. Free radical metabolism of antiparasitic agents
28. Involvement of superoxide dismutase and pyruvate: Ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica
29. Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori
30. The mode of action of metronidazole in Helicobacter pylori: Futile cycling or reduction
31. Proposed mechanism for metronidazole resistance in Helicobacter pylori
32. The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori
33. Metronidazole-resistant clinical isolates of Trichomonas vaginalis have lowered oxygen affinities
34. Metronidazole resistance and microaerophily in Campylobacter species
35. Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori
36. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: Repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance
37. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase
38. Identification of carboxylation enzymes and characterization of a novel four-subunit pyruvate: Flavodoxin oxidoreductase from Helicobacter pylori
39. Flavodoxin-dependent pyruvate oxidation, acetate production and metronidazole reduction by Helicobacter pylori
40. Helicobacter pylori porCDAB and oorDABC genes encode distinct pyruvate: Flavodoxin and 2-oxoglutarate: Acceptor oxidoreductases which mediate electron transport to NADP
41. The complete genome sequence of the gastric pathogen Helicobacter pylori
42. Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori rdxA + (nitroreductase) gene
43. Frequent association between alteration of the rdxA gene and metronidazole resistance in French and North African isolates of Helicobacter pylori
44. Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637
45. The role of the rdxA gene in the evolution of metronidazole resistance in Helicobacter pylori
46. Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates
47. Mechanism of metronidazole resistance in Helicobacter pylori: Comparison of the rdxA gene sequences in 30 strains
48. Transfer of the metronidazole resistance gene
49. Characterization of the rdxA and frxA genes in metronidazole resistant Helicobacter pylori strains
50. Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori
51. Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori
52. Frame-shift mutations in NAD(P)H flavin oxidoreductase encoding gene (frxA) from metronidazole resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance
53. Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori
54. Mouse-colonizing Helicobacter pylori SS1 is unusually susceptible to metronidazole due to two complementary reductase activities
55. Isolation of a genetic locus associated with metronidazole resistance in Helicobacter pylori
56. Isolation of the Helicobacter pylori recA gene and involvement of the recA region in resistance to low pH
57. Helicobacter pylori uptake and efflux: Basis for intrinsic susceptibility to antibiotics in vitro
58. Emergence of acquired-multidrug resistant Helicobacter pylori among clinical isolates
59. Nitroimidazole resistance in Helicobacter pylori
60. Targeted disruption of the gene encoding the classical nitroreductase enzyme in Salmonella typhimurium Ames test strains TA1535 and TA1538
61. Electrochemical characteristics of nitroheterocyclic comounds of biological interest. VIII. Stability of nitro radical anions from cyclic voltammetric studies
62. Metronidazole and cancer
63. Metronidazole and cancer
64. Prenatal exposure to metronidazole and risk of childhood cancer: A retrospective cohort study of children younger than 5 years
65. Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy
66. Short-term infection with Helicobacter pylori and 1 week exposure to metronidazole does not enhance gastric mutation frequency in transgenic mice
67. Differentiation of metronidazole-sensitive and -resistant strains of Helicobacter pylori by immunoblotting with antisera to the RdxA protein